首页> 美国卫生研究院文献>Cancer Science >Exome‐wide single‐base substitutions in tissues and derived cell lines of the constitutive Fhit knockout mouse
【2h】

Exome‐wide single‐base substitutions in tissues and derived cell lines of the constitutive Fhit knockout mouse

机译:Fhit基因敲除小鼠的组织和衍生细胞系中的全基因组单碱基替代

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Loss of expression of Fhit, a tumor suppressor and genome caretaker, occurs in preneoplastic lesions during development of many human cancers. Furthermore, Fhit‐deficient mouse models are exquisitely susceptible to carcinogen induction of cancers of the lung and forestomach. Due to absence of Fhit genome caretaker function, cultured cells and tissues of the constitutive Fhit knockout strain develop chromosome aneuploidy and allele copy number gains and losses and we hypothesized that Fhit‐deficient cells would also develop point mutations. On analysis of whole exome sequences of Fhit‐deficient tissues and cultured cells, we found 300 to >1000 single‐base substitutions associated with Fhit loss in the 2% of the genome included in exomes, relative to the C57Bl6 reference genome. The mutation signature is characterized by increased C>T and T>C mutations, similar to the “age at diagnosis” signature identified in human cancers. The Fhit‐deficiency mutation signature also resembles a C>T and T>C mutation signature reported for human papillary kidney cancers and a similar signature recently reported for esophageal and bladder cancers, cancers that are frequently Fhit deficient. The increase in T>C mutations in −/− exomes may be due to dNTP imbalance, particularly in thymidine triphosphate, resulting from decreased expression of thymidine kinase 1 in Fhit‐deficient cells. Fhit‐deficient kidney cells that survived in vitro dimethylbenz(a)anthracene treatment additionally showed increased T>A mutations, a signature generated by treatment with this carcinogen, suggesting that these T>A transversions may be evidence of carcinogen‐induced preneoplastic changes.
机译:Fhit是一种肿瘤抑制因子和基因组看守者,在许多人类癌症的发展过程中,在肿瘤前病变中都失去表达。此外,Fhit缺陷小鼠模型极易受肺癌和前胃癌的致癌物诱导。由于缺乏Fhit基因组看守者功能,本构性Fhit基因敲除菌株的培养细胞和组织发展出染色体非整倍性和等位基因拷贝数的得失,我们推测Fhit缺陷细胞也将发生点突变。在对Fhit缺陷组织和培养细胞的整个外显子组序列进行分析时,我们发现相对于C57B16参考基因组,外显子组中2%的基因组中有300至> 1000个与Fhit丢失相关的单碱基取代。突变特征的特征在于增加的C> T和T> C突变,类似于在人类癌症中识别出的“诊断年龄”特征。 Fhit缺乏症突变特征还类似于人类乳头状肾癌报道的C> T和T> C突变特征,以及最近报道的食管癌和膀胱癌(经常是Fhit缺乏症)的类似特征。 -/-外显子组中T> C突变的增加可能是由于dNTP失衡,特别是在三磷酸胸苷中,是因为Fhit缺陷细胞中胸苷激酶1的表达降低。在体外二甲基苯并(蒽)蒽处理中存活的Fhit缺陷肾细胞还显示出T> A突变增加,这是用这种致癌物治疗产生的特征,这表明这些T> A的转变可能是致癌物诱导的前肿瘤改变的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号